MedTrace Logo

Toradol (Ketorolac) in Breast Surgery to Reduce Pain & Opioid Use

NCT04439396 · Status: COMPLETED · Phase: PHASE1 · Type: INTERVENTIONAL · Enrollment: 183

Last updated 2023-02-10

No results posted yet for this study

Summary

The purpose of this study is to investigate whether perioperative single-dose administration of ketorolac (Toradol) can reduce post-operative pain after breast surgery, thereby decreasing post-operative opioid use.

Conditions

  • Breast Reduction
  • Breast Reconstruction

Interventions

DRUG

Ketorolac Tromethamine

nonsteroidal anti-inflammatory drug

OTHER

Saline

saline fluid injection

Sponsors & Collaborators

  • Carilion Clinic

    lead OTHER

Principal Investigators

  • James Thompson · Carilion Clinic

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
TRIPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
64 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-06-22
Primary Completion
2023-01-30
Completion
2023-01-30
FDA Drug
Yes

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04439396 on ClinicalTrials.gov